Literature DB >> 8484133

Autoantibody studies in juvenile rheumatoid arthritis.

J M Lawrence1, T L Moore, T G Osborn, G Nesher, K L Madson, M B Kinsella.   

Abstract

Early studies showed few immunologic abnormalities in juvenile rheumatoid arthritis (JRA) patients. There were no specific laboratory markers useful for diagnosis and assessment of the course of disease in JRA. Previous work showed an association of antinuclear antibodies (ANA) with early-onset pauciarticular disease and iridocyclitis. Similarly, the presence of 19S immunoglobulin (Ig) M rheumatoid factors (RF) was associated with late-onset polyarticular disease in girls. More recent studies have detected many unique autoantibodies. Newer assays show 19S IgM RF in up to 35% of JRA patients, although still mainly in girls with late-onset polyarticular disease. Hidden 19S IgM RF can be shown in up to 75% of JRA patients using different procedures, primarily in those with active polyarticular-or pauciarticular-onset disease. Immune complexes have been detected in JRA patients by means of different techniques; their presence usually correlates with active disease. Studies on a specific ANA in JRA have shown no common extractable nuclear antigen, but antihistone antibodies have been found in up to 75% of cases, again mainly in those with pauciarticular onset and iritis. Finally, a variety of unusual immunologic proteins have also been detected, including anti-ocular, anti-cellular, anti-cardiolipin, anti-perinuclear factor, and anti-collagen antibodies. This review evaluates the significance of these antibodies that can now be found in JRA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484133     DOI: 10.1016/0049-0172(93)80074-p

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  8 in total

Review 1.  Juvenile rheumatoid arthritis in India--rarity of antinuclear antibody and uveitis.

Authors:  A Aggarwal; R N Misra
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

Review 2.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

3.  Clinical application of tests used in rheumatology.

Authors:  Amita Aggarwal
Journal:  Indian J Pediatr       Date:  2002-10       Impact factor: 1.967

4.  Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Authors:  R Gupta; M M Thabah; B Vaidya; S Gupta; R Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2010-02-05       Impact factor: 1.967

5.  Serum IgM rheumatoid factor by enzyme-linked immunosorbent assay (ELISA) delineates a subset of patients with deforming joint disease in seronegative juvenile rheumatoid arthritis.

Authors:  A Aggarwal; S Dabadghao; S Naik; R Misra
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Authors:  T Avcin; R Cimaz; F Falcini; F Zulian; G Martini; G Simonini; V Porenta-Besic; G Cecchini; M O Borghi; P L Meroni
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

Review 7.  A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus.

Authors:  Xin Huang; Qing Zhang; Huilin Zhang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-22       Impact factor: 8.667

Review 8.  Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody for juvenile idiopathic arthritis.

Authors:  Yan Wang; Fengyan Pei; Xingjuan Wang; Zhiyu Sun; Chengjin Hu; Hengli Dou
Journal:  J Immunol Res       Date:  2015-02-19       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.